CasLoc logo
All Cases PTAB Litigations UPC Oppositions

ViiV Healthcare UK Ltd. v. Teva Pharmaceuticals USA Inc.

1:11-cv-00688

Overview

Case Number 1:11-cv-00688
Filing Date 2011-08-05
Status Terminated
Termination Date 2013-02-28
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

2 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

10 Attorneys Listed

Rivka Jungreis

UNDELIVERABLE EMAIL 6/9/14

Natasha E. Daughtrey

Email: ndaughtrey@goodwinlaw.com

Lauren M. Nowierski

Email: lnowierski@goodwinprocter.com

Joshua A. Whitehill

Email: jwhitehill@kasowitz.com

Ira J. Levy

Email: ilevy@goodwinlaw.com

Eric H. Yecies

Email: eric.yecies@hklaw.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David M. Hashmall

Email: dhashmall@goodwinlaw.com

Annemarie Hassett

Delivery failure 5/22/15

Delivery failure 5/22/15

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Plaintiff

ViiV Healthcare Co. Operating Company

Represented By

2 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

ViiV Healthcare UK Ltd. Operating Company

Represented By

5 Attorneys Listed

F. Christopher Mizzo

Email: chris.mizzo@kirkland.com

Craig T. Murray

Email: craig.murray@kirkland.com

Charles A. Fernandez

Email: charles.fernandez@kirkland.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials 2 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 2 U.S. Courts: 2
USPTO PTAB Trial 2015-01-08
IPR2015-00550

Teva Pharmaceuticals USA, Inc. v. ViiV Healthcare Co. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2014-06-02
IPR2014-00876

Apotex Corp. v. ViiV Healthcare Co.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2014-03-21
1:14-cv-00369

ViiV Healthcare UK Ltd. v. Lupin Ltd.

Asserted Patent
Status: DED
U.S. District Court 2011-06-29
1:11-cv-00576

ViiV Healthcare UK Ltd. v. Lupin Ltd.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6417191
Synergistic combinations of zidovudine, 1592U89 and 3TC
Filed: 1996-03-28
Issued: 2002-07-09
Expired (Term Ended)
Expires: 2016-03-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-927842.) - filed by ViiV Healthcare UK Ltd., ViiV Healthcare Co.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dzs, ) (Entered: 08/08/2011)

Entry #1 • 2011-08-05
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dzs, ) (Entered: 08/08/2011)

Entry #2 • 2011-08-05
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,417,191;. (dzs, ) (Entered: 08/08/2011)

Entry #3 • 2011-08-05
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/27/11. Date of Expiration of Patent: 3/28/16.Thirty Month Stay Deadline: 12/27/2013. (dzs, ) (Entered: 08/08/2011)

Entry #4 • 2011-08-05
1

Disclosure Statement pursuant to Rule 7.1 filed by ViiV Healthcare Co., ViiV Healthcare UK Ltd. identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc. for ViiV Healthcare UK Ltd.; Corporate Parent ViiV Healthcare UK Ltd. for ViiV Healthcare Co.. (dzs, ) (Entered: 08/08/2011)

Entry #5 • 2011-08-05
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc